Wednesday, November 22, 2017 10:39:29 AM
I don't see where I blamed anyone or showed anything worth blaming someone for.
I simply questioned your point of view that there was "plenty of companies" to learn from and that "study" would not turn up the pitfalls we have faced.
Blame?
I give the people here a crap load of credit.
Some of us are very good at digging up info.
I don't remember anyone pointing out all the pitfalls here and some people who spend all their days here would have LOVED to point those pitfalls out.
There were a few. The biggest being MARD IMO.
Someone on the "basher" side pointed this out. They said we would never get in because MARD wouldn't let us.
They were partially right. MARD was an obstruction.
Does anyone think Kim didn't know about MARD?
Many here have had years to "study" and still can't produce pitfalls we still face.
So maybe Kim should have spent the last 2 years studying and trying to identify the pitfalls before he faced them.
But then we would still need to face them wouldn't we?
Knowing a pitfall is coming doesn't mean you avoid it.
Kim hit expected and unexpected pitfalls along the way.
Study would not have really helped since 90% of them are unknown until you go through them.
I simply questioned your point of view that there was "plenty of companies" to learn from and that "study" would not turn up the pitfalls we have faced.
Blame?
I give the people here a crap load of credit.
Some of us are very good at digging up info.
I don't remember anyone pointing out all the pitfalls here and some people who spend all their days here would have LOVED to point those pitfalls out.
There were a few. The biggest being MARD IMO.
Someone on the "basher" side pointed this out. They said we would never get in because MARD wouldn't let us.
They were partially right. MARD was an obstruction.
Does anyone think Kim didn't know about MARD?
Many here have had years to "study" and still can't produce pitfalls we still face.
So maybe Kim should have spent the last 2 years studying and trying to identify the pitfalls before he faced them.
But then we would still need to face them wouldn't we?
Knowing a pitfall is coming doesn't mean you avoid it.
Kim hit expected and unexpected pitfalls along the way.
Study would not have really helped since 90% of them are unknown until you go through them.
Recent KBLB News
- From Genetic Puzzle to Industrial Platform • GlobeNewswire Inc. • 04/08/2026 01:31:34 PM
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
- Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength • GlobeNewswire Inc. • 02/27/2026 02:45:46 PM
- Biotech and Big Tech Drive the Morning Narrative • GlobeNewswire Inc. • 02/24/2026 03:17:14 PM
- 24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger • GlobeNewswire Inc. • 02/23/2026 02:36:14 PM
- Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue • GlobeNewswire Inc. • 02/23/2026 12:05:00 PM
- $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum • GlobeNewswire Inc. • 02/19/2026 04:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 04:17:09 PM
- 24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough • GlobeNewswire Inc. • 02/18/2026 01:45:00 PM
- AI, Advanced Materials and Enterprise Security Drive Small-Cap Momentum • GlobeNewswire Inc. • 02/17/2026 03:11:28 PM
- Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program • GlobeNewswire Inc. • 02/17/2026 12:05:00 PM
- 24/7 Market News - Not Magic, Just Science: Kraig Labs’ Transgenic Silkworms Make History at Scale • GlobeNewswire Inc. • 02/11/2026 01:35:00 PM

